The University of Chicago Header Logo

Connection

Renslow Sherer to HIV-1

This is a "connection" page, showing publications Renslow Sherer has written about HIV-1.
Connection Strength

0.570
  1. Darunavir in the treatment of HIV-1 infection: a viewpoint by Renslow Sherer. Drugs. 2007; 67(18):2802-3.
    View in: PubMed
    Score: 0.234
  2. HIV, HAART, and hyperlipidemia: balancing the effects. J Acquir Immune Defic Syndr. 2003 Oct 01; 34 Suppl 2:S123-9.
    View in: PubMed
    Score: 0.187
  3. The importance of potency and durability in HIV patient antiretroviral therapy preferences: a telephone survey. AIDS Patient Care STDS. 2005 Dec; 19(12):794-802.
    View in: PubMed
    Score: 0.054
  4. Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients. J Infect Dis. 2004 Jul 15; 190(2):280-4.
    View in: PubMed
    Score: 0.049
  5. Improving adherence to antiretroviral therapy. AIDS Read. 2003 Feb; 13(2):81-2, 85-6, 88-90.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.